Drug Discovery

(redirected from Drug candidate)
The process of developing a therapeutically active substance for a defined target molecule or pathway
References in periodicals archive ?
Its flagship drug candidate PreHistin is an allergy prevention medication in Phase III clinical development.
Xencor's product development is led by a protein therapeutic drug candidate, XPro[TM]1595, for the treatment of inflammatory disorders and an antibody candidate, XmAb[TM]2513, for the treatment of Hodgkin's Disease and T-cell lymphoma.
We are proud that this drug candidate has achieved this important milestone in what we believe is the first systemically administered Hedgehog antagonist tested in a clinical setting," said Curis President and CEO Dan Passeri.
CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular drug dipyridamole and an unconventionally low dose of the steroid prednisolone.
Amgen Obtains Option on Cytokinetics' Drug Candidate CK-1827452
The search for agents that increase the production and/or release of ACh, which can be used alone or in combination with AChE inhibitors, may therefore yield a drug candidate with significant clinical benefit.
To address these shortcomings, the industry is looking for ways to shorten the drug development timeline, while improving the quality and safety of each drug candidate.
a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, announced today that its lead oncology drug candidate, STA-4783, has been granted Fast Track designation by the U.
These losses primarily reflect the Company's efforts in advancing its clinical drug candidate, IMO-2055 in cancer, and pre-IND lead candidate, IMO-2125 in infectious disease.
Revance), today announced it has initiated a Phase Ib clinical trial of the Company's lead drug candidate, a topically delivered botulinum toxin type A gel for the treatment of facial lines and wrinkles.
Its flagship drug candidate PreHistin[TM] is an allergy prevention medication in Phase III Clinical development.